Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenues
Premiums	$ 9,156	$ 11,454	$ 21,892	$ 23,057
Net investment income	236	321	474	611
TOTAL REVENUES	67,178	60,523	132,680	117,778
Benefits and expenses
Pharmacy and other service costs	53,268	44,492	101,666	85,923
Medical costs and other benefit expenses	7,749	9,515	18,247	18,955
Selling, general and administrative expenses	3,433	3,684	7,646	7,389
Amortization of acquired intangible assets	422	420	844	843
TOTAL BENEFITS AND EXPENSES	64,872	58,111	128,403	113,110
Income from operations	2,306	2,412	4,277	4,668
Interest expense and other	(337)	(375)	(699)	(697)
Gain (loss) on sale of businesses	0	0	41	(19)
Net investment gains (losses)	52	(48)	50	(1,884)
Income before income taxes	2,021	1,989	3,669	2,068
TOTAL INCOME TAXES	389	360	628	651
Net income	1,632	1,629	3,041	1,417
Less: Net income attributable to noncontrolling interests	100	81	186	146
SHAREHOLDERS' NET INCOME	$ 1,532	$ 1,548	$ 2,855	$ 1,271
Shareholders' net income per share
Basic (in dollars per share)	$ 5.76	$ 5.51	$ 10.63	$ 4.48
Diluted (in dollars per share)	$ 5.71	$ 5.45	$ 10.55	$ 4.43
Pharmacy revenues
Revenues
Revenue from contract with customer	$ 53,649	$ 45,101	$ 102,282	$ 87,137
Fees and other revenues
Revenues
Revenue from contract with customer	$ 4,137	$ 3,647	$ 8,032	$ 6,973